SBRA · Sabra Health Care REIT, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Beds/units | 37,043 | as of June 30, 2026 | — |
| Behavioral health facilities | 16 | as of June 30, 2026 | — |
| Cash NOI (Same Store) non-GAAP | $28.56M | Three Months Ended June 30, 2026 | — |
| Cash NOI - Consolidated Senior Housing - Managed non-GAAP | $40.07M | Three Months Ended June 30, 2026 | — |
| Consolidated Enterprise Value | $7.9B | As of June 30, 2026 | — |
| Cost of Permanent Consolidated Debt non-GAAP | 3.92% | As of June 30, 2026 | — |
| Debt as a % of Asset Value | 37% | As of June 30, 2026 | — |
| Interest savings from hedged variable rate exposure | $7M | last 12 months | — |
| Investments | 395 | As of June 30, 2026 | — |
| Investments in loans receivable | 11 | as of June 30, 2026 | — |
| Liquidity | $1.3B | As of June 30, 2026 | — |
| Real estate properties held for investment | 364 | as of June 30, 2026 | — |
| Relationships | 61 | As of June 30, 2026 | — |
| Same property managed senior housing Cash NOI (year-over-year) non-GAAP | 13.7% | Q2 2026 | — |
|
|
|||
| Senior housing - leased communities | 32 | as of June 30, 2026 | — |
| Senior housing - managed communities | 94 | as of June 30, 2026 | — |
| Skilled Mix | 39% | As of June 30, 2026 | — |
| Skilled nursing/transitional care facilities | 207 | as of June 30, 2026 | — |
| Specialty hospitals and other facilities | 15 | as of June 30, 2026 | — |
| Unencumbered Assets/Unsecured Debt non-GAAP | 265% | As of June 30, 2026 | — |
| Weighted average effective interest rate on permanent debt | 3.92% | As of June 30, 2026 | — |
| Weighted average number of common shares outstanding, diluted - AFFO and Normalized AFFO non-GAAP | 256,733,670 | Three Months Ended June 30, 2026 | — |
| Weighted average number of common shares outstanding, diluted - Normalized FFO non-GAAP | 255,912,180 | Three Months Ended June 30, 2026 | — |
| Workforce diversity - ethnic minorities self-identified | 34% | As of June 30, 2026 | — |
| Workforce diversity - women in management/leadership roles | 58% | As of June 30, 2026 | — |
| Workforce diversity - women in workforce | 55% | As of June 30, 2026 | — |
| Wtd. Avg. Remaining Lease Term | 7 | As of June 30, 2026 | — |
| AFFO per share non-GAAP | $0.39 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Annualized Cash Net Operating Income - pro rata non-GAAP | $543.39M | Q1 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Cash Net Operating Income - pro rata 138.68M
+404.71M Annualizing adjustments
= Annualized Cash Net Operating Income - pro rata 543.39M
|
|||
| Annualized Cash Net Operating Income, as adjusted - pro rata non-GAAP | $543.39M | Q1 FY2026 | — |
| Available borrowings under revolving credit facility | $645M | first quarter of 2026 | — |
| Cash net operating income non-GAAP | $138.68M | Three Months Ended March 31, 2026 | — |
|
|
|||
| Cash Net Operating Income - pro rata non-GAAP | $138.68M | Q1 FY2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net Operating Income - pro rata $38.98M
+$4K Non-cash revenue and expense adjustments
= Cash Net Operating Income - pro rata $38.98M
|
|||
| Cash NOI - Same Store Senior Housing - Managed non-GAAP | $23.5M | Three Months Ended March 31, 2026 | — |
| Cash NOI - Senior Housing - Managed Consolidated Portfolio non-GAAP | $34.72M | Three Months Ended March 31, 2026 | — |
| Cash NOI Margin % - Senior Housing - Managed Consolidated Portfolio non-GAAP | 29.8% | Three Months Ended March 31, 2026 | — |
| Common shares outstanding | 252.2M | As of March 31, 2026 | — |
| Common stock closing price | $19.23 | As of March 31, 2026 | — |
| FFO per share non-GAAP | $0.37 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Net operating income | $140.27M | Three Months Ended March 31, 2026 | — |
| Net Operating Income - pro rata | $140.27M | Q1 FY2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Operating Income - consolidated $39.08M
-$99K Net Operating Income attributable to noncontrolling interests
= Net Operating Income - pro rata $38.98M
|
|||
| Normalized AFFO per share non-GAAP | $0.39 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Normalized FFO per share non-GAAP | $0.38 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Number of Properties - Senior Housing - Managed Consolidated Portfolio | 90 | Three Months Ended March 31, 2026 | — |
| Number of Units - Senior Housing - Managed Consolidated Portfolio | 9,078 | Three Months Ended March 31, 2026 | — |
| Occupancy - Senior Housing - Managed Consolidated Portfolio | 84.5% | Three Months Ended March 31, 2026 | — |
| Property Count - Consolidated Real Estate Investments | 361 | As of March 31, 2026 | — |
| Property Count - Total Equity Investments | 377 | As of March 31, 2026 | — |
| Property Count - Total Investments | 395 | As of March 31, 2026 | — |
| Property Count - Total Triple-Net Portfolio | 271 | As of March 31, 2026 | — |
| Quarterly cash dividend per share | $0.3 | first quarter of 2026 | — |
| REVPOR - Same Store Senior Housing - Managed non-GAAP | $4,755 | Three Months Ended March 31, 2026 | — |
| Same property managed senior housing Cash NOI non-GAAP | 14.4% | first quarter of 2026 | — |
| Shares remaining outstanding under forward sale agreements | 23.7M | first quarter of 2026 | — |
| Adjusted EBITDA non-GAAP | 121.23M | Three Months Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP EBITDA 107.98M
-1.65M Income from unconsolidated joint ventures
+2.16M Distributions from unconsolidated joint ventures
+3.07M Stock-based compensation expense
+453K Acquisition and transaction costs
-407K Recovery of loan losses
+648K Impairment of real estate
-91K Other income
+9.06M Net loss on sales of real estate
= Adjusted EBITDA 121.23M
|
|||
| Adjusted EBITDA, as adjusted non-GAAP | 123.9M | Three Months Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Adjusted EBITDA 121.23M
+2.68M Adjustments for current period activity
= Adjusted EBITDA, as adjusted 123.9M
|
|||
| Adjusted EBITDA, as adjusted, annualized non-GAAP | 495.61M | Three Months Ended December 31, 2025 | — |
| AFFO attributable to Sabra Health Care REIT, Inc. non-GAAP | 361.57M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP FFO attributable to Sabra Health Care REIT, Inc. 360.87M
+11.36M Stock-based compensation expense
-1.02M Non-cash rental and related revenues
+7.97M Non-cash interest expense
-1.73M Non-cash portion of loss on extinguishment of debt
-1.05M Recovery of loan losses
+313K Other adjustments related to unconsolidated joint ventures
-15.14M Other adjustments
= AFFO attributable to Sabra Health Care REIT, Inc. 361.57M
|
|||
| Ample liquidity | $1.2B | current | — |
| Availability under at-the-market equity offering program | $482.9M | current | — |
| Borrowings unsecured | 98% | current | — |
| Cash NOI non-GAAP | $23.14M | Q4 FY2025 | — |
| Consolidated Portfolio Number of Properties | 87 | Three Months Ended December 31, 2025 | — |
| Consolidated Portfolio Number of Units | 8,677 | Three Months Ended December 31, 2025 | — |
| Consolidated Portfolio Occupancy | 84.8% | Three Months Ended December 31, 2025 | — |
| Consolidated Real Estate Investments Beds/Units | 36,412 | December 31, 2025 | — |
| Consolidated Real Estate Investments Total | 360 | December 31, 2025 | — |
| FFO attributable to Sabra Health Care REIT, Inc. non-GAAP | 360.87M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net income attributable to Sabra Health Care REIT, Inc. 155.61M
+187M Depreciation and amortization of real estate assets
-163K Depreciation and amortization of real estate assets related to noncontrolling interests
+7.58M Depreciation and amortization of real estate assets related to unconsolidated joint ventures
+3.52M Net loss (gain) on sales of real estate
+7.32M Impairment of real estate
= FFO attributable to Sabra Health Care REIT, Inc. 360.87M
|
|||
| Interest savings | $7.9M | last 12 months | — |
| Net Debt non-GAAP | 2.48B | December 31, 2025 | — |
| Net Operating Income - consolidated non-GAAP | 518.54M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net income 155.51M
+187M Depreciation and amortization
+112.49M Interest
+53.71M General and administrative
-1.05M Recovery of loan losses
+7.32M Impairment of real estate
+1.15M Loss on extinguishment of debt
-14.04M Other income
+3.52M Net (gain) loss on sales of real estate
-3.93M Income from unconsolidated joint ventures
+1.84M Income tax expense
+15.01M Sabra's share of unconsolidated joint ventures' Net Operating Income
= Net Operating Income - consolidated 518.54M
|
|||
| Normalized AFFO attributable to Sabra Health Care REIT, Inc. non-GAAP | 365.41M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP AFFO attributable to Sabra Health Care REIT, Inc. 361.57M
-1.52M Lease termination income, net of expense
+2.88M Cash portion of loss on extinguishment of debt
+0K Write-off of cash rental income
+2.47M Other normalizing items
= Normalized AFFO attributable to Sabra Health Care REIT, Inc. 365.41M
|
|||
| Normalized FFO attributable to Sabra Health Care REIT, Inc. non-GAAP | 352.91M | Year Ended December 31, 2025 | — |
GAAP → non-GAAP reconciliationGAAP FFO attributable to Sabra Health Care REIT, Inc. $360.87M
+$7.76M Write-offs of cash and straight-line rental income receivable and lease intangibles
-$1.52M Lease termination income, net of expense
+$1.15M Loss on extinguishment of debt
-$1.05M Recovery of loan losses
-$14.3M Other normalizing items
= Normalized FFO attributable to Sabra Health Care REIT, Inc. $352.91M
|
|||
| Number of Available Units | 6,194 | Q4 FY2025 | — |
| Number of Investments | 4 | December 31, 2025 | — |
| Number of Loans | 13 | December 31, 2025 | — |
| Number of Properties | 68 | Q4 FY2025 | — |
| REVPOR | $4,506 | Three Months Ended December 31, 2025 | — |
| Same store Cash Net Operating Income - pro rata non-GAAP | 23.14M | Three Months Ended December 31, 2025 | — |
| Same Store Operating Performance Number of Available Units | 6,194 | Three Months Ended December 31, 2025 | — |
| Same Store Operating Performance Number of Properties | 68 | Three Months Ended December 31, 2025 | — |
| Secured Debt as a % of Asset Value | 1% | current | — |
| SNF concentration | 35% | current | — |
| Top five relationships concentration | 48% | current | — |
| Total Debt/Asset Value non-GAAP | 37% | December 31, 2025 | — |
| Total Equity Investments | 376 | December 31, 2025 | — |
| Total Investments | 393 | December 31, 2025 | — |
| Unconsolidated Portfolio Number of Properties | 16 | Three Months Ended December 31, 2025 | — |
| Unconsolidated Portfolio Number of Units | 1,256 | Three Months Ended December 31, 2025 | — |
| Unconsolidated Portfolio Occupancy | 93.5% | Three Months Ended December 31, 2025 | — |
| Weighted average debt maturity | 4 | current | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SBRA
this stock
Sabra Health Care REIT, Inc.
|
$5.30B | +8.8% | +10.2% | 79.8 | 9.7% |
|
WELL
Welltower Inc.
|
$168.06B | +28.3% | +35.6% | 118.4 | 2.5% |
|
VTR
Ventas, Inc.
|
$47.09B | +18.6% | +18.5% | 170.0 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.66B | +30.3% | +4.5% | 60.7 | 3.3% |
|
OHI
Omega Healthcare Investors Inc
|
$14.03B | +3.7% | +13.2% | 16.5 | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SBRA | +1.1% | -2.7% | -0.1% | -2.7% | +8.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +0.6% | -5.6% | -13.5% | -5.6% | -4.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.